Search alternatives:
therapeutic resistance » therapeutic research (Expand Search), therapeutic response (Expand Search)
therapy resistance » chemotherapy resistance (Expand Search)
decrease stress » increase stress (Expand Search), increased stress (Expand Search), decreased across (Expand Search)
therapeutic resistance » therapeutic research (Expand Search), therapeutic response (Expand Search)
therapy resistance » chemotherapy resistance (Expand Search)
decrease stress » increase stress (Expand Search), increased stress (Expand Search), decreased across (Expand Search)
-
141
-
142
DataSheet1_A flavonoid-rich fraction of Euphorbia peplus attenuates hyperglycemia, insulin resistance, and oxidative stress in a type 2 diabetes rat model.docx
Published 2023“…<p>Background: Type 2 diabetes (T2D) is a metabolic disorder characterized by insulin resistance (IR) and hyperglycemia. Plants are valuable sources of therapeutic agents for the management of T2D. …”
-
143
DataSheet_1_Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin.pdf
Published 2021“…However, the rapid emergence of resistance toward doxorubicin threatens its clinical application, thus the need for combination therapy. …”
-
144
DataSheet_1_Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin.pdf
Published 2023“…However, the rapid emergence of resistance toward doxorubicin threatens its clinical application, thus the need for combination therapy. …”
-
145
DataSheet_1_Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin.pdf
Published 2021“…However, the rapid emergence of resistance toward doxorubicin threatens its clinical application, thus the need for combination therapy. …”
-
146
DataSheet_1_DHW-221, a Dual PI3K/mTOR Inhibitor, Overcomes Multidrug Resistance by Targeting P-Glycoprotein (P-gp/ABCB1) and Akt-Mediated FOXO3a Nuclear Translocation in Non-small...
Published 2022“…In conclusion, these results demonstrated that DHW-221, as a novel P-gp inhibitor, represents a prospective therapeutic candidate to overcome MDR in Taxol-resistant NSCLC treatment.…”
-
147
DataSheet_1_Multi-omics investigation of the resistance mechanisms of pomalidomide in multiple myeloma.docx
Published 2023“…</p>Results<p>Our findings revealed a consistent decrease in the levels of complement components in the pomalidomide-resistant group. …”
-
148
-
149
-
150
-
151
Presentation_1_Comparative Metabolomics Reveals Key Pathways Associated With the Synergistic Killing of Colistin and Sulbactam Combination Against Multidrug-Resistant Acinetobacter...
Published 2019“…<p>Background: Polymyxins are a last-line class of antibiotics against multidrug-resistant Acinetobacter baumannii. However, polymyxin resistance can emerge with monotherapy, highlighting the need for synergistic combination therapies. …”
-
152
-
153
-
154
-
155
-
156
Image_4_Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma.jpeg
Published 2024“…Background<p>Treatment-resistant glioblastoma (trGBM) is an aggressive brain tumor with a dismal prognosis, underscoring the need for better treatment options. …”
-
157
Image_6_Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma.jpeg
Published 2024“…Background<p>Treatment-resistant glioblastoma (trGBM) is an aggressive brain tumor with a dismal prognosis, underscoring the need for better treatment options. …”
-
158
Image_1_Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma.jpeg
Published 2024“…Background<p>Treatment-resistant glioblastoma (trGBM) is an aggressive brain tumor with a dismal prognosis, underscoring the need for better treatment options. …”
-
159
Image_5_Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma.jpeg
Published 2024“…Background<p>Treatment-resistant glioblastoma (trGBM) is an aggressive brain tumor with a dismal prognosis, underscoring the need for better treatment options. …”
-
160
Image_2_Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma.jpeg
Published 2024“…Background<p>Treatment-resistant glioblastoma (trGBM) is an aggressive brain tumor with a dismal prognosis, underscoring the need for better treatment options. …”